    
  
2025/3/17
                                                                              18 30             1  2                                  30 40                                                                                              PSA                                                              60                                                                     CT                                           CEA        AFP      CYFRA 21  1      NSE      CA 19  9                  PSA             CA125      CA 15  3                                              
    